tiprankstipranks
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
US Market

Sutro Biopharma (STRO) Income Statement

Compare
649 Followers

Sutro Biopharma Income Statement

Last quarter (Q3 2024), Sutro Biopharma's total revenue was $8.52M, a decrease of -49.66% from the same quarter last year. In Q3, Sutro Biopharma's net income was $-48.79M. See Sutro Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 153.73M$ 67.77M$ 61.88M$ 42.72M$ 42.74M
Gross Profit
$ 146.91M$ 59.48M$ 52.11M$ -34.24M$ -22.88M
Operating Expenses
$ 243.01M$ 196.72M$ 160.40M$ 113.78M$ 98.20M
Depreciation and Amortization
$ 6.82M$ 8.29M$ 9.77M$ 4.30M$ 4.78M
EBITDA
$ -67.92M$ -105.07M$ -98.52M$ -23.75M$ -46.62M
Operating Income
$ -89.28M$ -128.94M$ -98.52M$ -71.06M$ -55.47M
Other Income/Expenses
$ 677.00K$ 12.24M$ -7.01M$ 38.93M$ -276.00K
Pretax Income
$ -88.60M$ -116.70M$ -105.54M$ -32.13M$ -55.74M
Net Income
$ -106.79M$ -119.20M$ -108.67M$ -36.20M$ -55.74M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.78$ -2.35$ -2.36$ -1.11$ -2.43
Diluted EPS
$ -1.78$ -2.35$ -2.36$ -1.11$ -2.43
Weighted Average Shares Outstanding
60.16M 50.74M 46.12M 32.57M 22.96M
Weighted Average Shares Outstanding (Diluted)
60.16M 50.74M 46.12M 32.57M 22.96M
Currency in USD

Sutro Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis